We promote basic and clinical research in gene therapy, cell therapy and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.
To help you navigate our website we have identified some of the pages we feel might be most useful to you.
.jpg)
ESGCT would like to express our sadness and dismay at the loss of Dr. Manfred Schmidt. Manfred passed away on 13 January 2022, aged 54. We extend our sincere condolences to his family, friends and colleagues.
Dr. Manfred Schmidt was a pioneer in the gene and cell therapy field, with more than 25 years of experience in the sector. He was the Co-Founder and CEO of GeneWerk GmbH, based in Heidelberg, Germany. His most recent academic role was as Section Head of Molecular and Gene Therapy at the German Cancer Research Center, also part of the National Center for Tumor Diseases in Heidelberg, Germany.
